Millennium Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-97,033
Closed -$43K 7379
2022
Q4
$43K Buy
+97,033
New +$40.1K ﹤0.01% 5833
2022
Q1
Sell
-71,017
Closed -$48K 7902
2021
Q4
$48K Sell
71,017
-118,531
-63% -$211K ﹤0.01% 6485
2021
Q3
$650K Sell
189,548
-71,872
-27% -$224K ﹤0.01% 5101
2021
Q2
$993K Sell
261,420
-25,527
-9% -$106K ﹤0.01% 4674
2021
Q1
$1.78M Sell
286,947
-41,339
-13% -$366K ﹤0.01% 3647
2020
Q4
$2.58M Buy
328,286
+253,123
+337% +$2.32M ﹤0.01% 3029
2020
Q3
$763 Buy
+75,163
New +$769K ﹤0.01% 3320

Other funds holding MTCR

Millennium Management's MTCR Position: Q1 2023 in Review

Millennium Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 97,033 shares — an estimated $43K sold.

Millennium Management first reported a position in MTCR in Q3 2020 and held it in 7 quarters. The position peaked at $2.58M in Q4 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • Millennium Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 97,033 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $43K.
  • Millennium Management first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Millennium Management's Metacrine, Inc. Common Stock position peaked at $2.58M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.